News

Providers need time to prepare to implement the final rule, scheduled to go in effect Jan. 1, 2021, at a time when they are facing the coronavirus pandemic and its resulting financial issues.

Some stroke patients may fear contracting the coronavirus, while others who are isolated may not be discovered quickly enough.

The treatment may reduce the risk to healthcare workers because it reduces the duration and quantity of viral shedding.

Despite his high profile and the deep pockets of its investors, the Amazon, Berkshire Hathaway, JP Morgan Chase joint venture has so far shown limited progress on its aspirational tech-driven healthcare goals.

Recent data breaches in digital health platforms have raised awareness for privacy protection and questions over who is responsible.

Gilead Sciences committed to supplying approximately 607,000 vials over the next six weeks to treat an estimated 78,000 hospitalized patients.

One promising candidate is remdesivir, a drug originally developed for Ebola, which the FDA has approved for emergency use during the pandemic.

The test could detect COVID-19 infections in about six out of 10 people, and was nearly perfect in determining when an infection wasn't present.

Insurers get a one-week extension to finalize 2021 exchange plan applications, giving them time to analyze the effect of COVID-19 in setting premiums.

By incorporating referrals into a physicians' EHR and creating a focused group of specialists, the shift to value is made that much easier.